Lyfnua, Filmtabletten - 56 Swissmedic Key 68065002 Registration Holder MSD Merck Sharp & Dohme AG Name Lyfnua, Filmtabletten Date of registration 24.05.2022 Introduction of Sequence 24.05.2022 ATC-Classification Gefapixant (R05DB29) Revision date WHO WHO-DDD Valid until 23.05.2027 Index Therapeuticus (BSV) Show package size 56 Index Therapeuticus (Swissmedic) 03.01.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680680650028 Medication Code Synthetika Pharmacode Disponibility
Composition gefapixantum 45.00 mg ut gefapixanti citras, cellulosum microcristallinum, mannitolum, hypromellosum, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, magnesii stearas, Überzug: cera carnauba, hypromellosum, titanii dioxidum, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium 0.794 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Gefapixantum 45 mg
Inactive agents additional_information (Rubrum) Cellulosum Microcristallinum Cera Carnauba Überzug Crospovidonum E 172 color. Hypromellosum Magnesii Stearas Mannitol Natrii Stearylis Fumaras Pro Compresso Obducto Silica Colloidalis Anhydrica Titanium Dioxide Triacetinum
Source Data was imported : 04.06.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
